Gene · 2224
Papers2,695
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,695
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer. | Sci Prog | 2023 | 36718538 | PubTator, text mining | PubMed |
| Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene. | Calcif Tissue Int | 2023 | 36707436 | PubTator, text mining | PubMed |
| Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway. | Anticancer Res | 2023 | 36697063 | PubTator, text mining | PubMed |
| Biosynthesis of α-Bisabolol by Farnesyl Diphosphate Synthase and α-Bisabolol Synthase and Their Related Transcription Factors in Matricaria recutita L. | Int J Mol Sci | 2023 | 36675248 | PubTator, text mining | PubMed |
| WT1 Pulsed Human CD141+ Dendritic Cell Vaccine Has High Potential in Solid Tumor-Targeted Immunotherapy. | Int J Mol Sci | 2023 | 36675017 | PubTator, text mining | PubMed |
| Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications. | Int J Mol Sci | 2023 | 36674910 | PubTator, text mining | PubMed |
| Genetic screens reveal new targetable vulnerabilities in BAP1-deficient mesothelioma. | Cell Rep Med | 2023 | 36657447 | PubTator, text mining | PubMed |
| Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. | Clin Transl Med | 2023 | 36650113 | PubTator, text mining | PubMed |
| Review of bone health in women with estrogen receptor-positive breast cancer receiving endocrine therapy. | Womens Health (Lond) | 2023 | 36644991 | PubTator, text mining | PubMed |
| A systematic exploration of ginsenoside Rg5 reveals anti-inflammatory functions in airway mucosa cells. | J Ginseng Res | 2023 | 36644392 | PubTator, text mining | PubMed |
| Mitochondrial related genome-wide Mendelian randomization identifies putatively causal genes for multiple cancer types. | EBioMedicine | 2023 | 36634566 | PubTator, text mining | PubMed |
| Protein-Coding Region Derived Small RNA in Exosomes from Influenza A Virus-Infected Cells. | Int J Mol Sci | 2023 | 36614310 | PubTator, text mining | PubMed |
| Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma. | Int J Mol Sci | 2023 | 36614241 | PubTator, text mining | PubMed |
| Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study. | Bone Rep | 2023 | 36582190 | PubTator, text mining | PubMed |
| New insights into apicoplast metabolism in blood-stage malaria parasites. | Curr Opin Microbiol | 2023 | 36563485 | PubTator, text mining | PubMed |
| Farnesyl/geranylgeranyl diphosphate synthases regulate the biosynthesis of alarm pheromone in a unique manner in the vetch aphid Megoura viciae. | Insect Mol Biol | 2023 | 36533988 | PubTator, text mining | PubMed |
| Downregulation of HbFPS1 affects rubber biosynthesis of Hevea brasiliensis suffering from tapping panel dryness. | Plant J | 2023 | 36524729 | PubTator, text mining | PubMed |
Design, Synthesis, Molecular Docking, Dynamics and in vitro Evaluation of Novel 2-substituted-1-hydroxyethane-1, 1-bis(phosphonic acid) Derivatives as Human Farnesyl Pyrophosphate Synthase Inhibitors with Expected Anticancer Activity. | Curr Pharm Des | 2023 | 36476435 | PubTator, text mining | PubMed |
| Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma. | Drug Dev Res | 2023 | 36433690 | PubTator, text mining | PubMed |
| Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study. | Vet Med Sci | 2023 | 36398717 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2224/papers?page=17